These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 19648425)

  • 1. Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteraemia, bronchitis, or mortality.
    Johnstone J
    Evid Based Med; 2009 Aug; 14(4):109. PubMed ID: 19648425
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: pneumococcal vaccination does not prevent pneumonia, bacteraemia, bronchitis, or mortality.
    Cicutto L
    Evid Based Nurs; 2009 Jul; 12(3):74. PubMed ID: 19553411
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP Journal Club. Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality.
    Johnstone J
    Ann Intern Med; 2009 May; 150(10):JC5-4. PubMed ID: 19451560
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries.
    Ament A; Baltussen R; Duru G; Rigaud-Bully C; de Graeve D; Ortqvist A; Jönsson B; Verhaegen J; Gaillat J; Christie P; Cifre AS; Vivas D; Loiseau C; Fedson DS
    Clin Infect Dis; 2000 Aug; 31(2):444-50. PubMed ID: 10987703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumococcal vaccination in adults].
    Jonkers RE; Boersma WG
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):437-41. PubMed ID: 12666513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of pneumococcal vaccination--a prospective study in patients with longstanding emphysema and/or bronchitis.
    Franzen D
    Eur J Med Res; 2000 Dec; 5(12):537-40. PubMed ID: 11147998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.
    Ament A; Fedson DS; Christie P
    Clin Infect Dis; 2001 Dec; 33(12):2078-9. PubMed ID: 11700581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
    Mangtani P; Roberts JA; Hall AJ; Cutts FT
    Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
    Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC
    Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of mortality in pneumococcal bacteraemia.
    Balakrishnan I; Crook P; Morris R; Gillespie SH
    J Infect; 2000 May; 40(3):256-61. PubMed ID: 10908020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults.
    Fedson DS; Liss C
    Vaccine; 2004 Feb; 22(8):927-46. PubMed ID: 15161070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza and pneumococcal vaccination of the elderly in Taiwan.
    Chen YH; Liou SH; Chou CC; Su WL; Loh CH; Lin SH
    Vaccine; 2004 Jul; 22(21-22):2806-11. PubMed ID: 15246615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal bacteraemia and opportunities for prevention.
    Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
    N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination of the elderly against pneumococcal disease is cost-efficient. Mass vaccination of all aged 65 and over is recommended].
    Ortqvist A; Jönsson B; Baltussen R; Ament A
    Lakartidningen; 2000 Nov; 97(45):5120-5. PubMed ID: 11116891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
    Singh KP; Voolmann T; Lang SD
    N Z Med J; 1992 Oct; 105(943):394-5. PubMed ID: 1461592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
    Schembri S; Morant S; Winter JH; MacDonald TM
    Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.